5-Benzylidene-3-ethyl rhodanine

Research use only, not for human use.

5-Benzylidene-3-ethyl rhodanine(BTR-1) is an active anti-cancer agent. BTR-1 activates apoptosis and induces cell death.

5-Benzylidene-3-ethyl rhodanine(BTR-1) is an active anti-cancer agent. BTR-1 activates apoptosis and induces cell death.

BTR-1 (10, 50, 100, and 250 μM, 5 days) dose-dependently causes cytotoxicity in human leukemic cells, with IC50s of 8 and 6 μM at 48 and 72 h, respectively.Cell Viability AssayCell Line:T-cell leukemic cell lines Concentration:10, 50, 100, and 250 μM Incubation Time:5 days Result:Induced cytotoxicity in human leukemic cells in a dose-dependent manner.

——

——

Apoptosis

Apoptosis

Apoptosis

——

——

18331-34-5

249.35

C12H11NOS2

>98% (HPLC)

DMSO:25 mg/mL (100.26 mM)

CCN1C(=S)S\C(C1=O)=C/c1ccccc1

——

(-20℃)

With Ice Pack

≥ 2 years